Financial Ratios CleanSpace Holdings Limited
Equities
CSX
AU0000107831
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5000 AUD | +2.04% |
|
-7.41% | +8.70% |
Feb. 24 | CleanSpace Holdings Limited, H1 2025 Earnings Call, Feb 25, 2025 | |
Feb. 24 | CleanSpace Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2024 | CI |
Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | 29.96 | 27.7 | -21.15 | -21.96 | -10.94 | |||
Return on Total Capital | 44.4 | 34.18 | -23.85 | -24.71 | -12.41 | |||
Return On Equity % | 87.59 | 45.13 | -32.01 | -31.45 | -15.23 | |||
Return on Common Equity | 157.44 | 47.98 | -32.01 | -31.45 | -15.23 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 73.06 | 76.88 | 73 | 69.51 | 72.25 | |||
SG&A Margin | 42.82 | 39.36 | 167.13 | 152.53 | 91.74 | |||
EBITDA Margin % | 26.88 | 34.05 | -108.86 | -93.21 | -27.56 | |||
EBITA Margin % | 25.91 | 32.7 | -112.82 | -97.84 | -30.62 | |||
EBIT Margin % | 25.91 | 32.7 | -112.82 | -97.84 | -30.62 | |||
Income From Continuing Operations Margin % | 20.85 | 22.81 | -84.45 | -67.24 | -19.89 | |||
Net Income Margin % | 20.85 | 22.81 | -84.45 | -67.24 | -19.89 | |||
Net Avail. For Common Margin % | 20.85 | 22.81 | -84.45 | -67.24 | -19.89 | |||
Normalized Net Income Margin | 16.02 | 20.35 | -71.48 | -61.18 | -18.25 | |||
Levered Free Cash Flow Margin | 18.44 | 18.76 | -89.54 | -70.58 | -10.48 | |||
Unlevered Free Cash Flow Margin | 18.66 | 18.9 | -88.31 | -69.34 | -9.92 | |||
Asset Turnover | ||||||||
Asset Turnover | 1.85 | 1.36 | 0.3 | 0.36 | 0.57 | |||
Fixed Assets Turnover | 30.82 | 20.58 | 3.67 | 4.14 | 8.11 | |||
Receivables Turnover (Average Receivables) | 6.79 | 12.7 | 8.64 | 6.62 | 6.34 | |||
Inventory Turnover (Average Inventory) | 5.75 | 3.58 | 0.86 | 1.1 | 1.49 | |||
Short Term Liquidity | ||||||||
Current Ratio | 1.97 | 5.78 | 4.84 | 6.14 | 4.69 | |||
Quick Ratio | 1.79 | 5.14 | 4.22 | 5.07 | 3.81 | |||
Operating Cash Flow to Current Liabilities | 0.43 | 1.7 | -1.85 | -3.63 | -0.46 | |||
Days Sales Outstanding (Average Receivables) | 53.89 | 28.75 | 42.24 | 55.11 | 57.74 | |||
Days Outstanding Inventory (Average Inventory) | 63.7 | 101.87 | 422.78 | 333.31 | 245.65 | |||
Average Days Payable Outstanding | 40.64 | 27.3 | 96.02 | 56.29 | 38.11 | |||
Cash Conversion Cycle (Average Days) | 76.95 | 103.32 | 369 | 332.13 | 265.28 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 49.87 | 10.76 | 13.88 | 18.22 | 18.04 | |||
Total Debt / Total Capital | 33.28 | 9.72 | 12.19 | 15.41 | 15.28 | |||
LT Debt/Equity | 24.16 | 3.93 | 3.91 | 15.32 | 15.24 | |||
Long-Term Debt / Total Capital | 16.12 | 3.55 | 3.43 | 12.96 | 12.92 | |||
Total Liabilities / Total Assets | 57.58 | 19.69 | 22.43 | 24.23 | 26.68 | |||
EBIT / Interest Expense | 73.97 | 144.02 | -57.3 | -49.15 | -34.21 | |||
EBITDA / Interest Expense | 78.23 | 153.84 | -53.51 | -44.9 | -27.47 | |||
(EBITDA - Capex) / Interest Expense | 74.21 | 138.6 | -55.81 | -44.92 | -27.69 | |||
Total Debt / EBITDA | 0.62 | 0.25 | -0.29 | -0.37 | -0.89 | |||
Net Debt / EBITDA | -0.91 | -1.99 | 1.5 | 0.87 | 1.81 | |||
Total Debt / (EBITDA - Capex) | 0.66 | 0.28 | -0.28 | -0.37 | -0.88 | |||
Net Debt / (EBITDA - Capex) | -0.96 | -2.21 | 1.44 | 0.87 | 1.8 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 156.83 | 75.76 | -73.24 | -9.47 | 30.01 | |||
Gross Profit, 1 Yr. Growth % | 184.24 | 82.49 | -74.59 | -13.81 | 35.14 | |||
EBITDA, 1 Yr. Growth % | -1.02K | 123.64 | -187.09 | -22.7 | -61.56 | |||
EBITA, 1 Yr. Growth % | -785.22 | 123 | -194.04 | -21.69 | -59.31 | |||
EBIT, 1 Yr. Growth % | -785.22 | 123 | -194.04 | -21.69 | -59.31 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | -656.44 | 92.28 | -199.07 | -27.92 | -61.54 | |||
Net Income, 1 Yr. Growth % | -656.44 | 92.28 | -199.07 | -27.92 | -61.54 | |||
Normalized Net Income, 1 Yr. Growth % | -784.09 | 123.28 | -195.74 | -22.71 | -61.23 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | -656.45 | 85.45 | -197.41 | -27.92 | -61.65 | |||
Accounts Receivable, 1 Yr. Growth % | 196.3 | -74.22 | -8.22 | 46.81 | 28.37 | |||
Inventory, 1 Yr. Growth % | 121.03 | 151.4 | -18.78 | -20.14 | -4.17 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | 19.96 | 282.75 | -10.58 | -30.32 | -38.28 | |||
Total Assets, 1 Yr. Growth % | 196.17 | 120.98 | -24.37 | -24.46 | -10.09 | |||
Tangible Book Value, 1 Yr. Growth % | 772.48 | 504.86 | -26.93 | -26.18 | -12.96 | |||
Common Equity, 1 Yr. Growth % | 755.84 | 504.66 | -26.95 | -26.21 | -13 | |||
Cash From Operations, 1 Yr. Growth % | -589.74 | 185.86 | -196.58 | -7.97 | -85.56 | |||
Capital Expenditures, 1 Yr. Growth % | 318.81 | 332.09 | -64.92 | -99.13 | 471.98 | |||
Levered Free Cash Flow, 1 Yr. Growth % | -835.58 | 79.66 | -230.31 | -6.89 | -80.7 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | -883.38 | 78.88 | -227.54 | -6.86 | -81.4 | |||
Compound Annual Growth Rate Over Two Years | ||||||||
Total Revenues, 2 Yr. CAGR % | 91.75 | 112.48 | -31.42 | -50.78 | 8.49 | |||
Gross Profit, 2 Yr. CAGR % | 102.61 | 129.31 | -31.91 | -53.2 | 7.93 | |||
EBITDA, 2 Yr. CAGR % | 213.83 | 352.46 | 38.32 | -17.84 | -45.49 | |||
EBITA, 2 Yr. CAGR % | 169.78 | 289.93 | 43.48 | -14.08 | -43.55 | |||
EBIT, 2 Yr. CAGR % | 169.78 | 289.93 | 43.48 | -14.08 | -43.55 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | 132.38 | 227.1 | 38.02 | -15.5 | -47.35 | |||
Net Income, 2 Yr. CAGR % | 132.38 | 227.1 | 38.02 | -15.5 | -47.35 | |||
Normalized Net Income, 2 Yr. CAGR % | 157.66 | 290.83 | 44.85 | -13.87 | -45.26 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | 132.39 | 177.42 | 34.4 | -16.21 | -47.42 | |||
Accounts Receivable, 2 Yr. CAGR % | 116 | -12.6 | -51.36 | 16.07 | 37.28 | |||
Inventory, 2 Yr. CAGR % | 63.84 | 135.73 | 42.89 | -19.46 | -12.52 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.03 | 114.28 | 85 | -21.06 | -34.42 | |||
Total Assets, 2 Yr. CAGR % | 67.87 | 155.83 | 29.28 | -24.41 | -17.59 | |||
Tangible Book Value, 2 Yr. CAGR % | 92.03 | 626.45 | 110.23 | -26.56 | -19.84 | |||
Common Equity, 2 Yr. CAGR % | 92.17 | 619.37 | 110.17 | -26.58 | -19.87 | |||
Cash From Operations, 2 Yr. CAGR % | 108.23 | 277.93 | 66.16 | -5.72 | -63.55 | |||
Capital Expenditures, 2 Yr. CAGR % | 48.73 | 325.4 | 23.12 | -94.48 | -77.72 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | 131.09 | 262.74 | 51.47 | -3.57 | -57.61 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 141.5 | 273.54 | 49.54 | -4.79 | -58.38 | |||
Compound Annual Growth Rate Over Three Years | ||||||||
Total Revenues, 3 Yr. CAGR % | 81.06 | 86.28 | 6.5 | -24.77 | -31.97 | |||
Gross Profit, 3 Yr. CAGR % | 98.91 | 96.56 | 10.14 | -26.34 | -33.36 | |||
EBITDA, 3 Yr. CAGR % | 61.24 | 179.9 | 159.7 | 14.04 | -36.22 | |||
EBITA, 3 Yr. CAGR % | 53.11 | 152.77 | 141.22 | 17.35 | -33.03 | |||
EBIT, 3 Yr. CAGR % | 53.11 | 152.77 | 141.22 | 17.35 | -33.03 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | 43.87 | 118.16 | 119.67 | 11.15 | -35 | |||
Net Income, 3 Yr. CAGR % | 43.87 | 118.16 | 119.67 | 11.15 | -35 | |||
Normalized Net Income, 3 Yr. CAGR % | 54.13 | 145.65 | 143.03 | 17.59 | -33.99 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 95.48 | 95.71 | 9.2 | -35.42 | |||
Accounts Receivable, 3 Yr. CAGR % | 99 | 6.35 | -11.16 | -29.7 | 20.04 | |||
Inventory, 3 Yr. CAGR % | 27.26 | 88.97 | 65.26 | 17.7 | -14.66 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | -1.05 | 56.39 | 60.13 | 33.61 | -27.28 | |||
Total Assets, 3 Yr. CAGR % | 64.16 | 83.98 | 70.42 | 8.08 | -19.91 | |||
Tangible Book Value, 3 Yr. CAGR % | 96.88 | 181.49 | 237.84 | 48.32 | -22.28 | |||
Common Equity, 3 Yr. CAGR % | 96.97 | 181.59 | 235.62 | 48.27 | -22.31 | |||
Cash From Operations, 3 Yr. CAGR % | 48.28 | 132.98 | 139.83 | 36.46 | -49.56 | |||
Capital Expenditures, 3 Yr. CAGR % | 29.91 | 112.22 | 85.17 | -76.39 | -74.08 | |||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 112.18 | 156.13 | 17.86 | -43.6 | |||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 118.2 | 159.34 | 16.7 | -44.76 | |||
Compound Annual Growth Rate Over Five Years | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 22.79 | 9.38 | 7.29 | |||
Gross Profit, 5 Yr. CAGR % | - | - | 29.9 | 10.71 | 9.25 | |||
EBITDA, 5 Yr. CAGR % | - | - | 51.51 | 70.81 | 39.15 | |||
EBITA, 5 Yr. CAGR % | - | - | 49.03 | 63.56 | 35 | |||
EBIT, 5 Yr. CAGR % | - | - | 49.03 | 63.56 | 35 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 41.5 | 49.29 | 24.06 | |||
Net Income, 5 Yr. CAGR % | - | - | 41.5 | 49.29 | 24.06 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 50.35 | 60.93 | 33.95 | |||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 39.3 | 15.69 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | 13.27 | 10.14 | 5.73 | |||
Inventory, 5 Yr. CAGR % | - | - | 33.3 | 34.35 | 28.13 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 27.09 | 18.97 | 12.05 | |||
Total Assets, 5 Yr. CAGR % | - | - | 49.2 | 28.89 | 27.44 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | 102.12 | 64.46 | 90.02 | |||
Common Equity, 5 Yr. CAGR % | - | - | 102.15 | 64.48 | 89.24 | |||
Cash From Operations, 5 Yr. CAGR % | - | - | 55.81 | 62.24 | 12.88 | |||
Capital Expenditures, 5 Yr. CAGR % | - | - | 27.15 | -50.7 | -20.61 | |||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 54.15 | 18.27 | |||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 55.97 | 18.18 |
- Stock Market
- Equities
- CSX Stock
- Financials CleanSpace Holdings Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions